Peripheral Arterial Disease Trial, Recruiting NCT07588295 Sponsor: Maria Cecilia Hospital Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT07588295
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have chronic (long-term) coronary artery disease, which is a condition where the arteries supplying the heart are narrowed or blocked
  • People who have had a type of heart event called a non-ST elevation acute coronary syndrome, which is a form of chest pain or heart attack that shows a specific pattern on heart tests
  • People who experience chronic claudication (Rutherford II-III), meaning they have ongoing leg pain or cramping when walking due to poor blood flow, at a moderate level of severity
  • People who have critical limb ischemia (Rutherford IV-V), meaning they have severely reduced blood flow to a limb, causing rest pain or wounds that will not heal

Who may not be able to join:

  • People with severe kidney problems
  • People with serious heart valve disease
  • People with advanced heart failure
  • People with advanced liver disease
  • People with a long-term inflammatory or autoimmune condition (such as rheumatoid arthritis or lupus)
  • People who are currently taking anti-inflammatory medications
  • People who currently have an active infection
  • People who have recently had a surgical procedure (confirm with trial site for exact timeframe)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +390545217032

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Maria Cecilia Hospital
Registry
ClinicalTrials.gov
Start date
18 March 2024
Est. completion
1 December 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

presence of macrophages and their activation within coronary and peripheral atherosclerotic lesions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov